- Perimenopause, Menopause, and Postmenopausal Health 0.81 CE/0.81 Pharmacology CE
Presented by Professor Alice Teall, this course serves nurses on all levels to expand his/her knowledge base relating to physiological changes and non-pharmacological interventions in perimenopausal, menopausal, and postmenopausal female clients.
- Review physiologic changes related to menopause that affect wellness
- Identify non-pharmacologic recommendations to support perimenopausal health
- Treatment Decisions for Menopausal Health 1.25 CEs/0.5 Pharmacology CE
A continuation of her previous course offering Perimenopause, Menopause, and Postmenopausal Health, Professor Alice Teall summarizes pharmacologic recommendations for women to prevent and treat osteoporosis, cardiovascular disease, cancer, incontinence and dementia. She also presents pharmacologic considerations for the treatment of menopause symptoms.
- Summarize pharmacologic recommendations for women to prevent and treat osteoporosis, cardiovascular disease, cancer, incontinence and dementia
- Identify pharmacologic options and prescribing considerations for the treatment of menopausal symptoms
- Medications in Pregnancy 1.16 CEs/1.16 Pharmacology CEs
Cindy Anderson covers topics related to the use of medications in pregnancy. Principles of pharmacokinetics, factors used to determine the influence of drugs exposure during pregnancy and risk vs benefits are all considered.
- Identify factors used to determine the influence of drugs exposure during pregnancy
- Define underlying principles of pharmacokinetics and adaptations in pregnancy
- Consider clinical application of risks and benefits related to prescribing drugs in pregnancy
- Lactation Pharmacology 1.36 CEs/1.36 Pharmacology CEs
Cindy Anderson discusses topics related to lactating mothers and their infants. Lactation physiology is discussed along with topics including bioavailability, drug kinetics and infant health. She also discusses relationship of variables necessary for accurate determination of neonatal risk from maternal drug exposure.
- List four characteristics of drugs which promote transfer into human milk
- Identify three infant characteristics which influence the metabolism of drugs ingested via maternal milk
- Describe the relationship of variables necessary for accurate determination of neonatal risk from maternal drug exposure
- Outline general guidelines for recommendations regarding maternal drug use during lactation
- Hormonal Contraception 2.28 CEs/2.28 Pharmacology CEs
Randee L. Masciola teaches about hormonal contraception. Topics covered include pharmacodynamics, pharmacokinestics and pharmacotherapeutics of estrogen and progesterone. She also includes strategies to use while troubleshooting side effects and assessing and recommending the correct hormonal contraception of patients in the primary care setting. Considerations regarding special populations such as adolescents, males, and older women are also addressed.
- Appreciate for the background and significance of hormonal contraception
- Understand of the pharmacodynamics, pharmacokinestics, and pharmacotherapeutics of estrogen and progesterone
- Apply United States Medical Eligibility Criteria (USMEC) that may predispose women to potential adverse effect from hormonal contraception
- Assess and recommend appropriate hormonal contraception options to patient in primary care setting
- Construct therapy adjustment options when trouble shooting side effects
- Recognize and identify unique needs and prescribing issues of hormonal contraception for special populations